The quantum computing sector, particularly stocks like IONQ and D-Wave (QBTS), is presented as a high-conviction short opportunity due to a belief that the technology has no viable path to profitability. The speaker is especially bearish on QBTS, predicting its potential failure within the next two quarters because it lacks a marketable product. Other specific short-selling candidates mentioned include biotech firms INmune Bio (INMB) and Vore (VOR). In contrast, Meta Platforms (META) is highlighted as an attractive long-term investment, considered "still cheap" even at its large size. The bullish case for META is driven by its phenomenal and sustained revenue growth, which is expected to continue.

Quantum Computing Sector (IONQ, QBTS, RGTI)

The speaker is extremely bearish on the entire quantum computing sector, arguing that it is a "sham" built on a fundamental misunderstanding of the technology's practical applications. The core of his thesis is that these companies have no viable path to significant revenue or profitability.

• The "One Trick Pony" Problem: Quantum computers offer a massive speedup for only one specific type of problem: integer factorization (using Shor's algorithm). This is useful for cryptography but is not a large commercial market.
• Slower Than Classical Computers: For 99.99% of all other computing tasks, quantum computers are billions of times slower than traditional processors from companies like NVIDIA (NVDA). They have much slower clock speeds (e.g., 10,000 hertz for an ion trap computer vs. 2 billion hertz for an NVIDIA chip) and lack the necessary RAM and storage for modern applications like AI.
• No AI or Drug Discovery Application: The speaker dismisses claims that quantum computing will revolutionize AI or drug discovery. These fields require processing massive datasets (terabytes or petabytes), while current quantum computers can only handle a tiny amount of data (e.g., a 1,000-qubit machine holds about 100 bytes).
• The Threat to Crypto is Overstated: While a powerful quantum computer could theoretically crack Bitcoin (BTC) in seconds, the speaker believes this is 15 to 30 years away. By then, cryptography will have evolved to be "quantum secure," neutralizing the threat.
• Lack of New Algorithms: It has been 30 years since Shor's algorithm was discovered, and no other algorithm offering a similar "miracle speed-up" has emerged. The speaker is highly skeptical that one will be found.

Takeaways

• The speaker believes quantum computing stocks are massively overvalued and lack a fundamental business model. He expects them to "collapse" as they continue to post "shitty quarters" with minimal to no revenue.
• He argues that investors should not confuse the "cool" factor of the technology with a viable investment case. The practical limitations (speed, data storage) make them inferior to classical computers for almost all real-world problems.
• This is a strong contrarian and bearish view on a sector that has seen significant hype. The speaker is actively shorting stocks in this space.

IonQ (IONQ)

The speaker is particularly bearish on IonQ, which he uses as a prime example of the sector's flaws.

• No Real Business: He states bluntly, "they don't have a business, really" and have "no organic growth." He notes that their revenue growth last quarter was 0%.
• Poor Financials: He mocks the company's financials, pointing to a history of consistently large and growing operating losses (from -$26 million to -$72 million quarterly). He jokes that they will soon earn more from interest income on their cash than from actual business operations.
• A "Facade": He believes the company is trying to "build this facade" and that institutional investors "will not touch our stock" without being given warrants (a sign of a risky investment).

Takeaways

• The speaker sees IONQ as a prime short candidate. He believes the company's valuation is completely disconnected from its financial reality and business prospects.
• He expects the stock to "collapse at some point" due to its lack of organic growth and unsustainable cash burn.

D-Wave Quantum (QBTS)

The speaker's view on D-Wave is even more negative than his view on IonQ.

• "Even Dumber": He describes the company as "even dumber" than IonQ and "humorous."
• Imminent Failure: He predicts a rapid decline, stating it will only take "two quarters" for the company to fail because "nobody's buying their fucking box."
• No Story: He claims that unlike IonQ, D-Wave "don't even have a story to tell."

Takeaways

• This is an extremely bearish call. The speaker believes D-Wave is a worthless enterprise on the brink of failure due to a complete lack of a viable product or customer base.

Meta Platforms (META)

In stark contrast to his views on quantum computing, the speaker is bullish on Meta.

• Still Cheap: Despite its $2 trillion market cap, he believes "Facebook is still cheap" and "pretty attractive."
• Incredible Growth: He highlights the company's phenomenal and consistent revenue growth, noting it achieved a 10x increase in revenue over 10 years.
• Not Saturated: He argues that the company is "not reaching an obvious saturation point" and is still figuring out how to continue growing revenue.

Takeaways

• The speaker sees META as a quality company that remains an attractive investment even at its large size.
• The key bullish driver is its proven track record of massive, sustained revenue growth, which he believes can continue.

INmune Bio (INMB)

The speaker holds a clear and concise bearish position.

• Active Short Position: He explicitly states, "No, I'm still short INMB."
• He expresses frustration with the company, calling it "stupid" and difficult to research.

Takeaways

• The speaker has a strong negative conviction on INMB and is actively betting against the stock.

Gilead Sciences (GILD)

The speaker is cautiously optimistic about Gilead's future.

• Well-Managed Company: He describes GILD as a "well-managed company" and is "pretty hopeful" it can return to growth.
• HIV Dominance: He believes Gilead will continue to "dominate HIV" due to a lack of competition in the space.
• Catalysts and Risks:
  • Risk: A "therapeutic plateau" where its drugs go generic is a headwind.
  • Catalyst: A new "twice-a-year shot" for HIV could be a major growth driver.

Takeaways

• The speaker has a long-term, cautiously bullish outlook on GILD. He sees it as a solid company with a strong market position.
• Investors should watch for the performance of its new long-acting treatments as a key indicator of future growth.

Other Mentioned Stocks & Themes

• SoundHound (SOUN): Briefly mentioned as a short opportunity.
• Vore (VOR): He notes the stock is "coming back down," which he "likes," suggesting interest at a lower price. However, he analyzes a recent financing deal involving heavy dilution and warrants and concludes, "Welcome to short," indicating the deal is a bearish catalyst.
• CoreWeave (Private): Mentioned as an attractive private company in the AI space. He notes that it's possible to "go long CoreWeave" through another publicly traded company that has invested in it, though he does not name the public company.
• NVIDIA (NVDA): Used as the gold standard for high-performance computing. His entire bearish thesis on quantum is built on the idea that NVIDIA's classical computers are, and will remain, vastly superior for all practical purposes, which is an implicitly bullish take on NVIDIA's competitive moat.
• Contrarian Investing Philosophy: The speaker shares his core strategy: "I like to short at Max Euphoria. I like to buy at Max Payne." This means selling into extreme optimism and buying into extreme pessimism and fear.